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a  b  s  t  r  a  c  t
Public  health  interventions  have  unique  characteristics  compared  to  health  technologies,  which  present
additional  challenges  for  economic  evaluation  (EE).  High  quality  EEs  that  are  able  to  address  the  particular
methodological  challenges  are  important  for public  health  decision-makers.  In England,  they  are  even
more pertinent  given  the transition  of public  health  responsibilities  in  2013  from  the  National  Health
Service  to local  government  authorities  where  new  agents  are  shaping  policy  decisions.
Addressing  alcohol  misuse  is  a globally  prioritised  public  health  issue.  This article  provides  a system-
atic  review  of EE  and  priority-setting  studies  for interventions  to  prevent  and  reduce  alcohol  misuse
published  internationally  over  the  past  decade  (2006–2016).  This  review  appraises  the EE  and  priority-
setting  evidence  to establish  whether  it is sufficient  to meet  the  informational  needs  of  public  health
decision-makers.
619 studies  were identified  via  database  searches.  7  additional  studies  were  identified  via hand  search-
ing  journals,  grey  literature  and  reference  lists.  27  met  inclusion  criteria.  Methods  identified  included
cost-utility  analysis  (18),  cost-effectiveness  analysis  (6),  cost-benefit  analysis  (CBA)  (1), cost-consequence
analysis  (CCA)  (1) and  return-on-investment  (1).  The  review  identified  a lack  of consideration  of  method-
ological  challenges  associated  with  evaluating  public  health  interventions  and  limited  use  of methods
such  as  CBA  and  CCA  which  have been  recommended  as  potentially  useful  for EE  in  public  health.  No
studies  using  other  specific  priority-setting  tools  were  identified.
© 2017  The  Authors.  Published  by  Elsevier  Ireland  Ltd.  This  is an open  access  article  under  the  CC  BY. Introduction
An increasing need for high quality economic evaluations of
ublic health interventions is recognised and has been documented
y academics and other commentators [1–4]. Characteristics
nique to public health, compared to healthcare technologies,
resent additional challenges to the evaluation of public health
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interventions. The reach of public health intervention conse-
quences is much broader than healthcare technologies where
commonly an individual beneficiary can be identified and the out-
come of interest is health maximisation. The time lag between
intervention and effect can also be considerably longer in public
health, compared to a health technology, where the aim is often
to prevent future morbidity; this poses evaluative challenges in
the form of discounting future costs and benefits and modelling
of longer-term effects. Costs incurred and benefits experienced in
the present are generally valued greater than those in the future,
therefore when modelling interventions with long-term costs and
benefits a discount rate should be applied to reflect the reduced
value of future costs and benefits to a decision-maker today; the
discount rate applied may  affect the outcome of an economic eval-
uation, therefore must be chosen carefully.
The reported paucity of high quality economic evaluations in
public health may  in part be due to a lack of consensual method-
article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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logical guidance on the conduct of economic evaluations in this
rea [5–7]. The unique challenges for evaluating public health per-
aps make the use of common evaluative methods, for which
uidelines exist for their conduct and reporting [8–10], such as
ost-utility analysis, insufficient for the task. Consequently, alterna-
ive methods for which there is less established guidance in health
are may  need to be used resulting in public health economists
sing a heterogeneity of evaluative methods [11]. The lack of guid-
nce may  also be behind the poor quality of many evaluations
hat have been published [12] since a lack of consensus over the
ethods to use and the costs and consequences to include [13,14]
ould contribute to results of varying quality. This lack of method-
logical consensus prevents easy comparison between different
ublic health interventions by decision-makers and is unhelpful
or researchers conducting such evaluations.
Several reviews have been conducted looking at methods of
conomic evaluation in public health [2,3,5]. Edwards et al. [5] con-
ucted a comprehensive review of guidance documents to identify
otential gaps in instruction for public health evaluations, however
his review did not look at how evaluations are actually being con-
ucted in practice. Owen et al. [2] focussed on the cost-effectiveness
f published National Institute of Health and Care Excellence (NICE)
ublic health guidance which limited the review to consider only
valuations that have been used by NICE. Weatherly et al. [3] iden-
ified evaluative challenges via a review of evaluations that have
een conducted on a range of public health interventions. Whilst
his review was comprehensive, it is limited to evaluations pub-
ished between the years 2000–2005 thus will not have captured
valuations that have been conducted since recent guidance on
ublic health economics has been released. For example, the major-
ty of the guidance documents identified by Edwards et al. [5] was
ublished after 2005.
In the UK, English public health responsibilities were transferred
o local authorities in 2013. The result of this move is that pol-
cy decisions are being shaped and influenced by new agents, such
s locally elected politicians. How prioritization decisions will be
ade, using which approaches, in this new context merits scrutiny
15]. Alongside this shift in the public health context in England
nd to address the lack of methodological guidance, NICE published
pdated guidance on the evaluation of public health interventions
16]. It recommended that the wider societal and environmental
osts and benefits of public health interventions should be consid-
red via greater use of methods such as cost-benefit analysis (CBA)
nd cost-consequence analysis (CCA) (see NICE glossary [17] p.216
or definitions of CBA and CCA).
This study will build on the evidence provided by existing
eviews and look at economic evaluations of public health inter-
entions around alcohol prevention, a globally prioritised issue
18–20]. The review will identify evaluations from 2006 to 2016
o capture evidence that has been published since Weatherly et al.
3] conducted their study and since recent recommendations for
ethods of evaluating public health interventions have been pub-
ished [5]. This review will also look at methods of priority-setting,
uch as option appraisal, (social) return-on-investment (ROI/SROI),
rogramme budgeting and marginal analysis (PBMA) and multi-
riteria decision analysis (MCDA), to help meet the needs of new
ublic health decision-makers [15,21].
PBMA and MCDA are both systematic processes to aid resource
rioritization decisions which involve assessing the available
ptions against a set of criteria (see [22,23] for detailed expla-
ations). SROI studies demonstrate the return on an investment
onsidering a wider remit than standard ROI as the benefits to
ociety are also included. Public Health England [24] recently rec-
mmended this tool for use by commissioners in drug and alcohol
reatment areas, however it may  also prove beneficial for invest-21 (2017) 1249–1262
ment decisions around non-treatment related alcohol prevention
interventions.
1.1. Aims and objectives
This review aims to identify the methods of evaluation being
used to appraise interventions to prevent excessive alcohol
consumption and establish whether published studies provide suf-
ficient information to meet the requirements of public health
decision-makers. Particular focus will be given to CBA and CCA,
as recommended by NICE, as well as prioritization tools such as
PBMA and MCDA. Specific elements of evaluation, inspired by the
work of Weatherly et al. [3] and guidance on methods of pub-
lic health appraisal [25], will provide a focus for the literature
search; guidance specific to the United States has also been pub-
lished [26] although this review will be focusing on the more recent
guidance produced by NICE. Such elements include: measurement
of outcomes, especially long-term outcomes; study perspectives;
apportioning inter-sectoral costs and consequences; and health-
equity considerations.
2. Methods
A systematic literature review was  carried out by one researcher
with assistance from an information specialist and two  other
researchers who  co-screened records and verified data extraction.
Details of the protocol for this systematic review were regis-
tered on PROSPERO and can be accessed at www.crd.york.ac.uk/
PROSPERO/display record.asp?ID=CRD42016039063.
2.1. Literature search
A literature search (see Table 1 for main search terms) was car-
ried out in the NHS Economic Evaluation Database (NHS EED) and
Scopus for the time period January 2006 − May  2016. NHS EED
is a database of economic evaluations which have been identi-
fied through a systematic search of the literature by the Centre
for Research and Dissemination (CRD) in York. Since methods of
priority-setting are not included in the search strategy used by the
CRD, an additional search was conducted in Scopus, limited to the
health and social sciences sector, to capture additional priority-
setting studies.
The NHS EED database ceased to be updated from 31st December
2014, therefore a further search was  conducted on the databases
searched by CRD (Medline, Embase, psychINFO and Cinahl) using a
strategy based on that used by CRD in order to capture economic
evaluations published between January 2015 and May  2016 (Full
search strategies for each database can be viewed in Appendix A
of the supplementary material). A hand search of relevant health
economics and economics journals was  also conducted alongside
reference and citation searches of included items.
Grey literature, in the form of public health/health economic
conference abstracts, OpenGrey, governmental departments and
voluntary organisations’ websites and dissertation and thesis
abstracts via ProQuest, was also searched for additional records.
2.2. Eligibility criteria
Economic evaluations, defined as the comparative analysis of
alternatives with respect to their associated costs and health
consequences, or a method of priority-setting defined as a system-
atic method of deciding where investments (and disinvestments)
should be made to best meet the needs of communities, were
included for review. Studies were included if they evaluated a pub-
lic health intervention focussed on preventing alcohol misuse or
reducing excessive alcohol consumption. Interventions to prevent
S.R. Hill et al. / Health Policy 121 (2017) 1249–1262 1251
Table  1
Key search terms used in literature searches.
Search termsa
Economics
Health Economics
exp Economic Evaluation
exp Health Care Cost
exp “costs and cost analysis”
economic$ or cost or costs or costly or costing or price or prices or pricing or pharmacoeconomic$
value for money
budget$
(MCDA or PBMA)
“option appraisal”
“multi$ criteria decision analys$"
“program$ budget$ marginal analys$”
(Priority?setting adj2 method$).
“social return on investment”
(SROI or ROI).
“return on investment”
(intoxica$ or beer or wine)
*drinking behaviour
Alcoholic Beverages
*Binge Drinking
Alcohol Drinking
*Alcoholism
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Alcohol$ adj2 (“use disorder$o¨r abuse or beverage$ or addiction$ or consumption
a Exact search strategy differed between databases therefore full strategy not rep
lcohol misuse may  be targeted at populations at-risk of drinking to
revent future excessive consumption of alcohol or may  be targeted
t those who drink harmful levels of alcohol. The precise classi-
cation of “harmful” alcohol consumption can be defined using a
ariety of different measures and may  differ internationally; there-
ore no specific definition will be provided as inclusion criteria in
rder to allow for the inclusion of a range of studies internationally
nd in an array of settings. Examples of such preventive interven-
ions are: national policies such as minimum unit pricing of alcohol
r targeted interventions such as brief interventions in schools or
ospitals. Studies were not excluded by country of origin provided
hey were published in English.
Evaluations of pharmacotherapies were excluded as these
ould fall within Health Technology Assessment (HTA) rather
han public health evaluation, which often uses far more prescrip-
ive methodology, with the dominant method being cost-utility
nalysis [27]. Evaluations of treatments for alcohol dependency,
.g. detoxification or rehabilitation, were also excluded as these
ould not be considered preventive; treatments which are part of
 preventive regime, such as screening and brief intervention for
on-treatment seeking individuals, were included. Evaluations of
nterventions to prevent harm or injury caused as a result of alcohol
onsumption, such as traffic accidents resulting from drunk-driving
r risky sexual behaviour, were excluded unless the intervention
pecifically focussed on reducing alcohol consumption as a primary
bjective.
.3. Data extraction
Studies selected for full-text screen were downloaded into an
ndnote X7 literature database and reviewed against the inclusion
riteria. A data extraction form was developed based on items used
y Drummond et al. [28] in their review which considered sim-
lar data (see Appendix B in the supplementary material for an
xample data extraction). We  then added items relevant to this
tudy specifically, such as methods of priority-setting adopted. The
orm was piloted using the first five studies, reviewed and rele-
ant amendments made. The finalised data for extraction included:
ntervention and comparators, type of study (randomised con-
rolled trial, non-randomised study or modelling study), populationink$))
ted here.
and setting, study length, time-horizon for analysis, perspective,
method of economic evaluation or priority-setting, extrapolation of
data, reported justification, strengths and weaknesses of methods
used, outcomes measured, types of costs included, whether pro-
ductivity changes were accounted for and equity considerations.
3. Results
Six hundred and nineteen studies were retrieved from the
database search after deduplication. Initial screening by two
researchers (SH and YO) identified 45 studies for full text screen-
ing. A further 5 studies were identified from hand-searching key
journals and grey literature. Twenty-five studies were selected
for inclusion in the review. A hand-search of references and
citations of the included studies identified a further two  items
for review. A total of 27 items were included for review
[29–36,39–44,53,54,57,65,68,70,75–81] (Fig. 1).
The included studies were published between years 2006 and
2015, publication frequency was distributed fairly evenly across
the time period. Studies were conducted in the following coun-
tries: USA (n = 8), UK (n = 5), Australia (n = 5), Netherlands (n = 3),
Denmark (n = 2), Estonia (n = 1), Italy (n = 1), Sweden (n = 1) and
multi-national (OECD) (n = 1).
The most common primary method of economic evaluation
used was  cost-utility analysis (CUA) (n = 18) followed by cost-
effectiveness analysis (CEA) (n = 6), CCA (n = 1) and CBA (n = 1). Six
studies conducted multiple evaluations; four conducted a CEA as a
secondary analysis, one a ROI and one a cost-analysis.
One ROI study was identified. No studies using other priority-
setting methods were identified (Table 2).
3.1. Interventions
The most commonly evaluated intervention was  screening and
brief intervention (SBI) which was evaluated in 11/27 studies
followed by tax increases on alcohol (n = 7). The remaining inter-
ventions evaluated ranged from targeted interventions such as
family skills training and different screening variations to popu-
lation level interventions such as advertising bans and raising the
legal alcohol drinking age (Fig. 2).
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Table 2
Overview of studies included in the review and key details, numbered.
Study No. Author Year Country of study Title Intervention Comparator Method of analysisa
1 Angus, C. et al. 2014 Italy Cost-effectiveness of a programme of
screening and brief interventions for
alcohol in primary care in Italy
Alcohol screening and brief interventions
(SBI) in primary care. Two screening
options:
No intervention CUA
•  At next general practitioner (GP) visit
• At registration with GP
2  Barbosa, C. et al. 2015 United States The cost-effectiveness of alcohol
screening, brief intervention and
referral to treatment in emergency and
outpatient medical settings
Screening and brief intervention with
feedback, intervention or treatment
(SBIRT) to all individuals presenting for
emergency care but not specifically
seeking treatment for substance abuse.
SBIRT in outpatient care CUA & CEA
3  Barrett, B. et al. 2006 United Kingdom Cost-effectiveness of screening and
referral to an alcohol health worker in
alcohol misusing patients attending an
A&E department
Opportunistic identification of hazardous
drinking and referral to an alcohol health
worker. Adults attending A&E selectively
screened for alcohol misuse
Information only CEA
4 Byrnes,  J.M. et al. 2010 Australia Cost-effectiveness of volumetric
alcohol taxation in Australia
Volumetric alcohol taxation. Three tax
scenarios modelled:
Current tax policy CUA
•  Maintain current deadweight loss of
taxation
•  Maintain existing taxation revenue
•  Equate to existing rate for spirits
5 Cobiac, L. et al. 2009 Australia Cost-effectiveness of interventions to
prevent alcohol-related disease and
injury in Australia
Eight interventions evaluated (incl.
comparator):
Current Practice (i.e.
random breath testing)
CUA
•  Advertising bans
• Licensing controls restricting opening
hours
•  Brief intervention
• Residential treatment
•  Raise minimum drinking age
• Drink driving campaigns
• Volumetric taxation
6 Cowell, A.J. et al. 2012 United States Cost-effectiveness analysis of
motivational interviewing with
feedback to reduce drinking among a
sample of college students
Motivational interviewing, assessment and
feedback. Four intervention conditions
evaluated:
Incremental
comparison of all
interventions
CEA
•  Assessment only (AO)
• Motivational interviewing (MI)
•  Feedback (FB)
• Motivational interviewing and feedback
(MIFB)
7  Crawford, M.J. et al. 2014 United Kingdom The clinical and cost-effectiveness of
brief advice for excessive alcohol
consumption among people attending
sexual health clinics: a randomised
controlled trial
Opportunistic brief advice for excessive
alcohol use among people who attend
sexual health clinics
General health information
leaflet provided
CUA
8  Drummond, C. et al. 2009 United Kingdom Effectiveness and cost-effectiveness of
a  stepped care intervention for alcohol
use disorders in primary care: pilot
study
Stepped care alcohol intervention Brief intervention CUA
9  Havard, A. et al. 2012 Australia Randomized Controlled Trial of Mailed
Personalized Feedback for Problem
Drinkers in the Emergency
Department: The Short-Term Impact
Mailed personalised feedback after
screening in the emergency department
No mailed feedback CEA
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10 Holm, A.L. et al. (a) 2014 Denmark Cost-effectiveness of changes in
alcohol taxation in Denmark: a
modelling study
Alcohol taxation. Three tax scenarios
modelled in:
Current level of
taxation
CUA
•  20% increase in tax
•  100% increase in tax
• 10% decrease in tax
11 Holm, A.L. et al. (b) 2014 Denmark Cost-Effectiveness of Preventive
Interventions to Reduce Alcohol
Consumption in Denmark
Six interventions to reduce alcohol
consumption:
Current practice for
each intervention
CUA
•  30% increase in tax
•  Raise minimum drinking age
• Advertising bans
• Limited retail sale hours
• Brief telephone intervention
•  Longer intervention in prevention
centres
12  Ingels, J.B. et al. 2013 United States Cost-effectiveness of the strong African
American families-teen programme:
1-year follow-up
Family skills training to reduce substance
abuse in African American adolescents
Attention control
intervention
CEA
13 Kapoor,  A. et al. 2009 United
States
Cost-effectiveness of screening for
unhealthy alcohol use with%
carbohydrate deficient transferrin:
results from a literature-based decision
analytic computer model
Screening for unhealthy alcohol abuse
using a%CDT test. Four scenarios modelled:
Incremental
comparison of all
interventions
CUA
•  AUDIT questionnaire only
• %CDT test only
• AUDIT questionnaire followed by%CDT
test
•  No screening
14 Lai,  T. et al. 2007 Estonia Costs, health effects and
cost-effectiveness of alcohol and
tobacco control strategies in Estonia
Five different strategies to reduce alcohol
consumption:
No intervention and
incremental
comparison of all inter-
ventions/interventions
in combination
CUA
•  Excise tax
• Reduced access to alcoholic beverage
retail outlets
• Advertising ban
• Roadside breath-testing
• Brief intervention in primary care
15  Mansdotter, A.M. et al. 2007 Sweden A cost-effectiveness analysis of alcohol
prevention targeting licensed premises
A three component intervention:
community mobilisation, a two-day
responsible beverage service training
course for servers, doormen, and
restaurant owners and increased
enforcement of alcohol laws
No direct comparator CCA & CA
16  Miller, T.R. et al. 2007 United States Effectiveness and benefit-cost of
peer-based workplace substance abuse
prevention coupled with random
testing
Peer-based workplace substance abuse
prevention (PeerCare) with random
alcohol testing
PeerCare programme
without alcohol testing
ROI
17  Miller, T.R. & Hendrie, D. 2008 United States Substance Abuse Prevention Dollars
and Cents: A Cost-Benefit Analysis
School based interventions to prevent
substance abuse (alcohol and drugs and
tobacco).
No direct comparator CBA
18 Navarro, H.J. et al. 2011 Australia The potential cost-effectiveness of
general practitioner delivered brief
intervention for alcohol misuse:
evidence from rural Australia
Screening and brief intervention (SBI) for
risky drinking by a general practitioner.
Three levels of SBI increase modelled:
Current practice CEA
•  10% increase
•  20% increase
•  100% increase
1254
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Table 2 (Continued)
Study No. Author Year Country of study Title Intervention Comparator Method of analysisa
19 Neighbors, C.J. et al. 2010 United States Cost-effectiveness of a motivational
intervention for alcohol-involved
youth in a hospital emergency
department
Motivational interviewing amongst youths
admitted to the emergency department of
a trauma ward for drinking-related injuries
Standard care CUA & CEA
20 Purshouse,  R.C. et al. 2013 United
Kingdom
Modelling the cost-effectiveness of
alcohol screening and brief
interventions in primary care in
England
Alcohol screening and brief interventions
(SBI) in primary care. Two screening
options:
Current practice CUA
•  At next general practitioner (GP) visit
• At registration with GP
21 Sassi,  F. et al. 2015 Multi-
national
Health and economic impacts of key
alcohol policy options
Multiple interventions examined: Interventions
compared to each
other intervention and
to other possible uses
of health funds
CUA
•  Brief interventions
• Tax increases
•  Drink-drive regulation enforcement
(breath-testing)
• Opening hours regulation
•  Treatment of dependence
• Advertising regulation
• Minimum price
• Workplace interventions
•  School-based programmes
22 Shanahan, M.  et al. 2006 Australia Modelling the costs and outcomes of
changing rates of screening for alcohol
misuse by GPs in the Australian context
Four strategies to improve screening and BI
rates for Australian GPs:
Current practice CEA
•  Academic detailing
• Interactive continuing medical
education
•  Computerised reminders
•  Target payments
23 Smit,  F. et al. 2011 Netherlands Modelling the cost-effectiveness of
health care systems for alcohol use
disorders: how implementation of
eHealth interventions improves
cost-effectiveness
eHealth interventions augmenting national
health care system. Two strategies
modelled:
Current practice (no
eHealth intervention)
CUA & ROI
•  Adding eHealth systems to conventional
care
• 50% substitution of conventional
face-to-face with eHealth interventions
24  Solberg, L.I. et al. 2008 United States Primary care intervention to reduce
alcohol misuse: ranking its health
impact and cost effectiveness
Screening and brief intervention in
primary care
No screening CUA
25  Tariq, L. et al. 2009 Netherlands Cost-effectiveness of an opportunistic
screening programme and brief
intervention for excessive alcohol use
in  primary care
Screening and brief intervention in
primary care
Current practice (no SBI) CUA & CEA
26 van  den Berg, M.  et al. 2008 Netherlands The cost-effectiveness of increasing
alcohol taxes: a modelling study
Two  alcohol tax increase scenarios: Current practice CUA &
CEA•  Increase tax on beer only (Dutch
scenario)
• Raise taxes to on beer, wine and spirits
(Swedish scenario)
27  Watson, J. et al. 2013 United Kingdom AESOPS: a randomised controlled trial
of  the clinical effectiveness and
cost-effectiveness of opportunistic
screening and stepped care
interventions for older hazardous
alcohol users in primary care
Opportunistic screening and stepped care
intervention in primary care (20 min
behavioural change counselling,
motivational enhancement therapy, local
specialist alcohol services)
Minimal intervention (brief
advice with
practice/research nurse)
CUA
a Interpreted by review authors, study authors’ stated methods sometimes differed from those stated here.
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Records identified throug h 
datab ase searching
(n=77 1)
Records identified throug h 
additiona l sources
(n=5)
Records screened after 
duplicates removed
(n=61 9)
Records exclud ed 
(n=574)
Full-text  articles assess ed 
for eli gibility
(n=50)
Full-text  articles exclud ed
(n=25)
Records identified from 
reference search
(n=2)
Studies included for review
(n=27)
Fig. 1. Prisma flow diagram.
Fig. 2. Frequency of intervention types evaluated.
a The frequency of interventions is greater than the total number of included studies due
*These interventions do not fit our inclusion criteria, however they were included in stud
criteria, therefore have been included in this figure for reference.21 (2017) 1249–1262 1255
The majority of interventions were targeted at specific “at-
risk” groups and therefore in settings such as primary care
(n = 13), hospital emergency departments (n = 4), hospital out-
patients departments (n = 1), schools/universities (n = 3), sexual
health clinics (n = 1), the community (n = 5) and the workplace
(n = 2). Seven studies evaluated interventions on a national level
setting (the frequency of study settings is greater than the total
number of included studies due to several studies considering mul-
tiple settings).
3.2. Study designs
Eight randomised, and one non-randomised, controlled trials
were included in the review; two of those [29,30] considered a
beyond-trial analysis longer than trial follow-up. Neighbors et al.
[29] did not specify the time horizon considered but used a deci-
sion analytic model to estimate the number of quality adjusted life
years (QALYs) saved for their CUA implying a time horizon longer
than trial analysis (6 months) was  considered; Mansdotter et al.
[30] used outcomes data from a previous study to extrapolate a
five year time horizon.
Eighteen modelling studies were identified; 10 of those under-
took long-term evaluations which were longer than 30 years
allowing for the long-term benefits of public health preventive
interventions to be captured. Data were taken from the epidemio-
logical literature, results from previous trials, longitudinal studies
and meta-analyses to populate models in order to estimate future
costs and outcomes.
 to several studies considering multiple interventions.
ies which evaluated a mix  of interventions, the rest of which did fit our inclusion
1256 S.R. Hill et al. / Health Policy 121 (2017) 1249–1262
Table 3
Number of studies by key study characteristics.
Study Characteristics Studies (n) Study numbers (Table 2)
Cost sectors
Healthcare 25 1, 2, 3, 4, 5, 7, 8, 9, 10, 11, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27
Education 3 6, 17, 21
Criminal Justice 6 2, 3, 8, 19, 24, 17
Law  enforcement 4 10, 11, 15, 17
Environment 0
Employment 0
Social care 7 3, 7, 8, 12, 20, 24, 27
Voluntary 2 3, 12
Private 2 15, 16
Out  of pocket 4 5, 12, 14, 24
Government 7 4, 5, 10, 11, 14, 21, 22
Othera 6 2, 8, 17, 19, 20, 24
Setting
Primary care 13 1, 2, 5, 8, 13, 14, 18, 20, 22, 23, 24, 25, 27
Hospital emergency departments 4 2, 3, 9, 19
Hospital outpatients departments 1 2
Community 5 12, 15, 23, 5, 11
National level (e.g. tax policy) 7 4, 5, 10, 11, 14, 26, 21
School/university 3 6, 17, 21
Sexual health clinics 1 7
Workplace 2 16, 21
Discounting
Costs
3%  13 1, 4, 5, 10, 11, 13, 14, 15, 16, 17, 19, 21, 24
3.5%  1 20
4.0% 2 25, 26
Outcomes
3%  10 1, 4, 5, 10, 11, 13, 14, 15, 24, 17
3.5% 1 20
1.5%  2 25, 26
No  discounting applied 11 2, 3, 6, 7, 8, 9, 12, 18, 22, 23, 27
Time  Horizon
<1 year 5 2, 6, 7, 8, 9
1–5  years 7 3, 12, 15, 16, 18, 23, 27
5–10 years 0
10–30 years 2 1, 20
>30 years/Lifetime 10 5, 10, 11, 13, 14, 17, 21, 24, 25, 26
Unspecified 3 4, 19, 22
Type of study
RCT 7 3, 6, 7, 8, 9, 12, 27
Non-randomised 1 15
Modelling study 18 1, 2, 4, 5, 10, 11, 13, 14, 16, 17, 18, 20, 21, 22, 23, 24, 25, 26
RCT  + modelling 1 19
Model type
Population model 1 14
ALCMOD 1 23
SAPM 2 20, 1
Multistate life table model 4 4, 5, 10, 11
Markov model 1 13
Decision analytic model 4 2, 18, 19, 22
Algebraic model 1 24
Chronic Disease Model 3 21, 25, 26
Statistical model 1 16
Unspecified 1 17
Stated Perspective
Healthcare (incl. social care for NHS PSS) 11 1, 4, 5, 7, 10, 11, 20, 23, 25, 26, 27
Societal 6 3, 12, 13, 14, 15, 19
Provider 2 6, 9
Societal + Healthcare 1 24
Societal + Provider 1 2
Societal + Government 1 17
Government 1 22
Employer 1 17
Unspecified 3 8, 18, 21
Productivity costs separately accounted for
Yes 4 2, 3, 15, 17
a o prop
3
cNo  23 
Other costs here refer to those related to automobile accidents, expenses related t.3. Inter-sectoral costs and consequences
Ten unique cost sectors were considered (Table 3); all studies
onsidered healthcare costs in their analyses with the exception1, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27
erty damage and insurance administration expenses.of two  studies [31,32] that did not. The perspective taken for
analysis determines the costs that will be considered since only
costs relevant to that perspective are included (i.e. a study tak-
ing a healthcare perspective will only consider healthcare costs).
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he two studies that did not include healthcare costs conducted
heir evaluations according to an educational provider and societal
erspective respectively. Whilst a societal perspective would tradi-
ionally include healthcare, this particular intervention was based
n non-healthcare community and voluntary services; in their lim-
tations, the authors note that healthcare resource utilisation costs
ere not included as would be expected in a full societal perspec-
ive.
Twelve studies stated the use of a healthcare perspective for
heir economic evaluation (Table 3). Of those twelve, three were
onducted according to a health and personal social services per-
pective, therefore those studies also included costs to the social
are sector. The perspective inferred from the stated costs included
n the studies’ analysis differed from the stated perspective on three
ccasions. These three studies [33–35] additionally included costs
o the government for implementing and enforcing the interven-
ions.
Nine studies claimed to follow a societal or other broad perspec-
ive (Table 3). This perspective is recommended for interventions
here benefits and costs fall outside of the healthcare sector as
s often the case for public health interventions. Similarly to the
tudies considering a healthcare perspective, there was  discrep-
ncy between the stated and inferred perspectives in some of the
tudies claiming to have considered a societal perspective. Two
tudies considered a very narrow range of costs. The perspective
sed by Mansdotter et al. [30] would be better interpreted as a
ayer perspective since only costs related to implementing the
ntervention are considered. Likewise, Kapoor et al. [36] consider
nly healthcare and out-of-pocket patient costs which is a very nar-
ow interpretation of the impacts to society. In addition, five of the
ine studies claiming to adhere to a societal perspective did not
xplicitly consider productivity costs (defined as work productivity
ost from illness) in their analyses, although one of those studies,
eighbors et al. [29], justified excluding estimates of productiv-
ty loss separately by stating that these are implicit in the QALY
stimate. This method of accounting for productivity losses is rec-
mmended by a number of organisations such as the US Panel on
ost-effectiveness analysis [9] and NICE [8], however this is not
niversally agreed on and those who disagree encourage specific
easurement of productivity costs [37,38].
The remaining studies conducted their analyses according to
ither an education, government, provider or employer perspec-
ive. The stated perspectives in these cases aligned with those
nferred from the costs reported. Three studies [39–41] did not
pecify a perspective.
None of the studies included consequences outside of the health
ector such as benefits from increased employment or to the
nvironment. The only non-health impacts considered were cost-
avings to the criminal justice sector as a result of reducing violence
evels and thus avoiding resultant costs to the judicial system
30,42].
.4. Equity
None of the identified studies specifically address or discuss
quity in health in their evaluations; however, inferences about
ffects on health inequalities may  be made from data reported in
ome of the identified studies. Three studies [36,43,44] included
ubgroup analysis in their evaluations which stratified outcomes
y gender, age and baseline alcohol consumption. Although not
onducted by the authors, the Sheffield Alcohol Policy Model used
y Purshouse et al. [44] allows for analysis by other variables such
s socioeconomic status which could provide relevant data for an
ssessment of health inequalities.21 (2017) 1249–1262 1257
4. Discussion
This review has confirmed the general paucity of economic eval-
uation studies in areas of public health that has been documented
previously [1–4]. Whilst this review can only comment on the sta-
tus of evaluations within the arena of alcohol prevention, it would
be reasonable to expect the results to be applicable to other areas
of public health policy since, compared to other policy areas, alco-
hol is not unique in terms of economic evaluation quality. A lack of
economic evaluation evidence is problematic for decision-making
generally since it limits the basis for accurate, evidence-informed
decisions to be made. However, there are a number of issues spe-
cific to public health decision making that have been highlighted
in this review. Four are reviewed in the following sub-sections.
4.1. Intervention coverage
Firstly, the identified literature included evaluations of pri-
mary prevention (more upstream) interventions (e.g. tax increases
or advertising bans), which impact at a whole population level,
and secondary/tertiary prevention (more downstream) interven-
tions (e.g. SBI), which target specific at-risk populations. The
World Health Organisation (WHO) and the Organisation for Eco-
nomic Co-operation and Development (OECD) have both promoted
upstream, preventive interventions to reduce harm from alcohol
(and public health generally) because of a belief in their superior
cost-effectiveness [45,46]. The literature identified in this review,
however, focussed more on the evaluations of secondary/tertiary
prevention interventions.
The plethora of articles evaluating interventions such as SBI may
in part be due to a general acknowledgement, promoted by organi-
sations such as the WHO  and the OECD and eminent academics such
as Sir Michael Marmot [47], that upstream interventions are gen-
erally cost-effective, thus inciting less perceived need to conduct
such evaluations. These interventions can, however, be politically
problematic to implement. Lobbying from interest groups and pres-
sure to please voters, particularly in areas whose economy relies
heavily on the food and beverages industry, prevents easy passage
of policies such as alcohol tax increases or limitations on access
[48,49]. Given the politically charged context of alcohol policy
decisions, economic evaluation evidence demonstrating the eco-
nomic benefits, in addition to health and other benefits, could prove
instrumental to the implementation of such interventions. Wanless
[50] argues that health and wealth go hand-in-hand − i.e. healthy
communities tend to be more economically productive − there-
fore if economic evaluations are also able to demonstrate positive
productivity gains from upstream alcohol policies, this could pro-
vide a further counter-argument to those lobbyists opposed to such
interventions.
Upstream interventions can also be more challenging to
evaluate methodologically since attributing effects that occur
downstream to an intervention is already often difficult. Exter-
nal factors will likely also affect the outcome of the intervention
making it difficult to disentangle its impact. An absence of suit-
able data to extrapolate the downstream consequences of upstream
interventions may  offer another explanation for fewer economic
evaluation studies of this type. Natural experiment studies can
provide a means of evaluating upstream interventions [51]; for
example, if policy implementation is staggered across different geo-
graphical areas and external factors can be assumed to be similar
across the regions.4.2. Long-term considerations
Secondly, the time-horizons adopted in some of the studies
were relatively short and may  not capture the impact of preven-
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ive interventions, the nature of which is to prevent uptake of
nhealthy habits in the future. Long-term health risks from over-
onsumption of alcohol, such as various chronic diseases [52],
evelop over a sustained period. These health risks are unlikely
o be captured in analytic time-horizons shorter than ten years.
ver half of the evaluations identified had time horizons of under
en years but the critical issue is whether the inclusion of longer
erm effects would have changed the conclusions. Extrapolation of
ata for a longer horizon of analysis would have been unlikely to
hange the conclusion of the majority of the trial studies however
t least three studies could have been strengthened from longer-
erm data. Crawford et al. [53] conclude that their intervention
f study is not cost-effective due to no significant differences in
osts or QALYs between control and intervention groups at six
onth follow up. Given the focus on sexual health in this study, six
onths may  be insufficient time to expect significant differences
n QALYs from participants; whereas a longer time horizon could
llow for any positive effects on participants’ drinking to mani-
est into better sexual health, and therefore a potential increase in
ALYs gained, in the long-run. Cowell et al. [32] evaluated their
ntervention using three month follow-up data, citing potential
ecline in intervention effectiveness after this point. Extrapola-
ions would have been useful to determine whether the transitory
ffect of the intervention still represents value for money. Given
hat Cowell et al. [32] collected data up to 12 months post-
ntervention, excluding the longer-term data for their evaluation
ay  also represent publication bias. A similar argument can be
ade for Havard et al. [54] who evaluate cost-efficacy at six weeks
ost-intervention. Six month follow-up is cited as underway, and
as subsequently been published [55] but there has been as yet
o re-estimation of cost-effectiveness based on these longer-term
ata.
Funding preventive interventions in public health, which mainly
roduce benefits that occur in the future, can be politically difficult
ue to an emphasis on meeting near-term targets [56]. Economic
valuations with long-term time-horizons are therefore impor-
ant in order to demonstrate, with some level of certainty, the
alue of diverting limited funds now into programmes that, while
ot alleviating problems in the immediate term, may  carry the
udos of achieving deferred benefits to be appreciated by someone
lse.
The limited proportion of studies considering the long-term
onsequences of interventions is predominantly driven by the
conomic evaluations of randomised controlled trials (RCTs). The
ajority of identified studies limited their analysis to a maxi-
um  of 12 months post intervention and focused on short-term
utcomes which may  in part be due to the cost and impracti-
alities of conducting RCTs with long-term follow up. Several of
he studies identified in this review comment on the importance
f understanding the long-term effects of the trial interventions
32,54,57], particularly considering potential diminishing inter-
ention effect over time. Long-term follow-up would be required
o definitively capture this; however incorporating trial results
nto a model alongside estimated data from literature on such
xternal factors could enable evaluations to reflect a longer-term
nalysis of the intervention. This would be most useful in uncer-
ain or costly cases, where modern modelling methods [1] could
e employed to assess the potential long-run value of an inter-
ention and aid better informed decision-making. However, it
ay  not be necessary to consider long-run effects of all inter-
ention trials, for example if an intervention is shown to be cost
ffective in the short-term and has a very low absolute cost; more efficient use of resources could be used to fund the
ntervention and monitor the outcomes than devote resources to
odelling.21 (2017) 1249–1262
4.3. Incorporating equity
Thirdly, addressing equity in health did not feature in any of the
evaluation studies despite this being a globally recognised area of
need [58]. This could be due to a lack of knowledge and available
guidance around how to include equity considerations in economic
evaluations or due to a lack of data with which to do so. If the latter
were the case however, one would expect this to be highlighted by
the authors in their study limitations, which is not the case in the
studies identified in this review.
Methods of incorporating equity are still in relative infancy in
the health economics literature, therefore it is unsurprising that
this element is largely missing from the evaluations identified in
this review. Recent research on methods to incorporate equity con-
siderations into economic evaluations via CEA has been published
[59,60]. Cookson et al. [59] suggest three possible approaches to
including health equity in economic evaluations: equity impact
analysis, equity constraint analysis and equity weighting analysis.
Equity impact analysis disaggregates relevant costs and outcomes
by equity-relevant sub groups producing a dashboard of various
costs and outcomes by sub group to assess who  benefits and who
loses from each policy option. Equity constraint analysis involves an
assessment of trade-offs between the fairness (in equity terms) and
cost-effectiveness of an intervention. In this analysis, equity is con-
sidered a constraint to seeking cost-effectiveness. Equity weighting
analysis attempts to quantify the value of health equity impacts in
order to analyse trade-offs between equity and health [61].
There is no evidence of attempts to address equity in the iden-
tified literature of this review using any of the three methods
discussed. Having said this, inferences may  be made from data
reported in some of the studies. Some discussion points raised by
authors, whilst not specifically targeting health equity, could be
inferred as pertinent. For example, in discussing the impracticality
of achieving the “optimal outcome” of their studied intervention,
Navarro et al. [41] touch on some equality-related issues such as
low adherence to the intervention by the most at-risk group of
drinkers (hazardous drinkers) and lack of access to young males
who are a particularly risky group.
The latter two  methods outlined by Cookson et al. [59,61], equity
constraint analysis and equity weighting analysis, may  be challeng-
ing to implement. However, it could be expected that an attempt
at equity impact analysis be included in an evaluation so that
decision-makers may  consider the effects on health equity along-
side efficiency.
4.4. Perspective
Finally, over half of the studies identified conducted their anal-
ysis according to a healthcare perspective. The Washington panel
on cost-effectiveness in health and medicine proposes the use of
the societal perspective in economic evaluations [9,10] and NICE
in the UK [16] recommends either a public sector or local gov-
ernment perspective as most appropriate for evaluations of public
health interventions. NICE’s recommendation stems from acknowl-
edgement that local government has responsibility for more than
just health, therefore this should be reflected in any analysis of
interventions funded by local authorities.
There are often time and resource constraints within studies
which prevent a comprehensive collection of all data required to
truly reflect a societal perspective [62] and some costs and benefits
may  be difficult to capture, such as productivity costs (discussed
earlier) or benefits to family members or carers who do not directly
benefit from an intervention. However, attempts should be made
to include as many costs and outcomes relevant to society within
the resources available; prioritising those that are likely to have the
greatest impact on the outcome of the evaluation. Where precise
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ata cannot be obtained, tools such as sensitivity analysis [63] can
e used to estimate the uncertainty imposed by the missing data.
Restricting the analysis of a public health intervention to
 healthcare perspective may  under-value an intervention if
ost-savings occur in other sectors or equally over-value the inter-
ention if costs are incurred on other sectors as a result of the
ntervention. Byford and Raftery [62] argue that the societal per-
pective is the only perspective that is truly able to address the
pportunity costs to societal welfare of the resources used for the
ervice when the providers of the service have responsibilities
eyond healthcare. Therefore, according to this argument, over half
f the recent evidence available to public health decision-makers
s limited to a perspective that is more restricted than their actual
emit, especially given the current emphasis on addressing the
ider determinants of health. However, there remains a lack of con-
ensus over what constitutes societal welfare and thus, which costs
nd benefits should be included and how these should be valued.
herefore, prescribing to a societal perspective for analysis implic-
tly applies a judgement on what is considered to be included in
he perspective which, it can be argued, is unlikely to be represent
 complete picture of all socially valuable effects [64].
One of the methodological challenges identified by Weatherly
t al. [3] was incorporating inter-sectoral costs and consequences.
he findings from this review echo the issues raised by Weatherly
nd colleagues and demonstrate that this challenge has not yet been
esolved. Several studies commented on difficulties incorporating
ertain costs and outcomes. Most limitations were around obtain-
ng accurate costs either in general [42,65] or specifically around
on-health costs required for a full societal perspective [31,39].
one of the studies were able to appropriately include non-health
utcomes in their analyses. Identifying methods for researchers to:
) obtain appropriate data on non-health costs and consequences
nd ii) incorporate non-health outcomes into analyses may  thus
e important areas of research to pursue in future. The latter point
rings with it additional limitations since the synthesis of costs
nd outcomes across sectors requires judgements on the related
pportunity costs, i.e. what benefits are displaced elsewhere by
iverting resources to a certain intervention. Considering the net
ffects of an intervention on the healthcare sector equivalent and
irectly comparable to wider society assumes that the opportunity
ost of displaced resources is also equivalent amongst the various
ectors. However, a unit of cost or outcome may  differ in value
etween sectors depending on the size of the sector’s budget and
he individual sector’s marginal productivity of producing a unit
f outcome [66]. In order to appropriately compare inter-sectoral
osts and consequences requires a value of net health benefits to be
xpressed equivalent to the value of net benefits to wider society
64].
An alternative approach to both adopting a societal perspective
nd synthesising potentially inequivalent costs and benefits could
e to adopt a multi-sectoral perspective in which the net effects
n each relevant sector are displayed in a disaggregated approach
64,66]. Decision-makers can then review the merits of the inter-
ention to each sector and make a judgement based on their own
nterpretation of the trade-offs in terms of costs and benefits to
he relevant sectors. The CCA method would be a useful tool to
epresent a multi-sectoral perspective since all costs and effects
re displayed in a disaggregated format for easy comparison. These
ould easily be displayed according to each sector. Whilst allow-
ng for a comprehensive presentation of costs and effects, CCA
lone has limitations. The disaggregated approach to presenting
esults in a CCA does not guide a transparent basis for decisions,
hrough the use of cost-effectiveness thresholds for example, which
an open-up the decision to scrutiny for possibly ‘cherry-picking’
esults.21 (2017) 1249–1262 1259
4.5. Cost-benefit analysis
A further option to incorporate multi-sector costs and benefits
is through the use of CBA [66]. However, despite suggestions for
greater use of CBA and CCA from organisations such as NICE, there
does not appear to have been a marked increase in the number of
either being published since previous reviews [2,3]. This could be
explained by a number of reasons. Firstly, NICE’s public health guid-
ance recommending the use of CBA and CCA was only published in
2012, therefore it may be too early to see its effect filtering into
published work. Secondly, NICE guidance, whilst accessible to any
researcher, is most relevant to UK studies and only 5 (19%) of the
studies are from UK institutions. Other countries have their own
standards for economic evaluation, for instance Angus et al. [43]
used QALYs because that fitted “standard practice for Italian CEA”
[43]. Thirdly, a lack of available data on relevant outcomes or prob-
lems monetising outcomes, for example Cowell et al. [32] stated
that CEA was chosen over CBA due to difficulty in monetizing health
outcomes. Finally, the most commonly used study perspective was
healthcare, therefore the adoption of a CEA or CUA approach is con-
sistent with this. Whether considering the healthcare perspective
meant that important costs and benefits were excluded, which may
have altered the studies’ conclusions, is another question.
Therefore, the question that needs to be asked is whether a lack
of CBA in the literature really matters. Utilising more CBA can be
argued for on the grounds of wanting to provide evaluations that
are a true reflection of the impact on society, as argued by Byford
and Raftery [62], or to incorporate means to address/evaluate the
wider determinants of health into economic evaluations which are
important to public health decision-makers. The reporting of CBA
results in monetary terms could be helpful when engaging in dis-
cussion with policy-makers who may  be unfamiliar with health
economics terminology; CBA may  be more readily understood and
therefore more likely to be universally accepted than a CUA, for
example.
However, the potential difficulties in monetising certain ben-
efits, such as health mentioned earlier, may  complicate efforts to
incorporate CBA more widely in public health evaluations. Also,
many of the evaluations labelled as “cost-benefit analyses” in the
literature were actually cost-analyses or CUAs [67,68] which does
not instil confidence in the execution of high quality CBA. For
example, the only CBA identified by this review [69] provides
no explanation of how the stated health benefits are monetised,
which raises concern over the reliability of the figures used and the
methodological quality of the evaluation. If quality of the study is at
stake, a well-executed CUA or CEA that may  not be able to address
all of a decision-maker’s informational needs could be preferable
to a poorly conducted CBA that attempts to meet those needs but
produces an inferior evaluation.
Additionally, the identified ROI study [70] was  reported as a
cost-benefit analysis; however, the benefits considered were solely
cost-savings and not monetised health, or other, benefits, there-
fore was not considered a true CBA by our definition [17]. CBA that
either consider only cost-savings or very narrow benefits such as
avoided fatalities (with no consideration of morbidity or quality of
life) have been reported for policies and interventions that would
be relevant to alcohol prevention and general public health in other
sectors, such as transport economics [71,72]. Whilst it is notewor-
thy that CBA is a respected method of economic evaluation in these
sectors, and provides scope for its use within alcohol prevention
public health, decision-makers should be mindful of whether CBA
accurately reflect all the relevant costs and benefits associated with
an intervention. There is clearly room for improvement on the oper-
ationalization of CBA within alcohol prevention and public heath
more broadly. Further research into willingness-to-pay or discrete
choice experiment studies to provide relevant data for measuring
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he benefits of public health interventions, would be beneficial.
ntil this gap in the evidence base is filled, perhaps a compromise
f including a CCA, which is able to provide additional data on costs
nd consequences relevant to a decision-maker without the strug-
le of valuing and synthesising them into a single metric, may  offer
 potential solution.
.6. Priority-setting
The general lack of published priority-setting studies in the alco-
ol prevention literature indicates that these methods are perhaps
ot yet widely considered to be useful by academics for this topic
rea, or that such methods are used in practice within local gov-
rnment or other agencies but not reported in academic or (easily
ccessible) grey literature. A brief search for priority-setting meth-
ds not limited to alcohol prevention did identify a small number
f studies conducted in public health more broadly and a similar
umber within the health technology and medical fields. This find-
ng, alongside recent research into priority setting in public health
15,21,73] provides scope for more incorporation of methods such
s PBMA, MCDA and SROI within the area of alcohol-prevention.
Methods such as PBMA and MCDA offer decision-makers the
dvantage of being able to make resource allocation decisions
sing a systematic and transparent approach. These approaches
llow for the consideration of multiple criteria, which is particu-
arly pertinent to a public health decision-maker whose interests
ikely extend beyond purely population health maximisation. This
s not to say, however, that pure economic evaluation methods can-
ot contribute to prioritization decisions. A number of the studies
dentified in this review demonstrated potential prioritization of
nterventions based on their economic evaluations. Cobiac et al.
33], as part of the Australian ACE-prevention project [74], analysed
ombinations of interventions to develop an “optimal intervention
ix” which suggests the order in which interventions should be
mplemented based on their cost-effectiveness. In this example a
league table” approach is used, however the ACE-prevention study
eam explicitly justify the evaluative rigour in their approach to
riority-setting compared to the standard league table approach.
Lai et al. [75], following guidance from the
HO-CHOICE methodology for economic evaluation
http://www.who.int/choice/en/), present their economic eval-
ation of multiple alcohol interventions as a cost-effectiveness
rontier in which an “expansion path” can be drawn to represent
he most efficient combination of interventions, indicating strate-
ies where resources could be prioritised. The authors [75] do
owever note the limitations of this approach given the political
nd public interests which also influence policy choices in reality.
he ability to address limitations such as this justifies greater use
f methods such as PBMA and MCDA.
. Strengths and limitations
This study reports the results of a detailed systematic review
hat identified literature using several databases to minimise the
isk of missing data. The searches were developed with the assis-
ance of an information specialist to ensure rigour in the search
trategies. Grey literature were also examined in order to capture
elevant unpublished work. Whilst attempts were made to iden-
ify relevant grey literature, this review may  not have captured
ll of these sources, for example reports perhaps conducted by
on-academic agencies that have not been externally published or
isseminated. The scope of this review was limited to interventions
hat directly aim to reduce or prevent the misuse of alcohol and did
ot include interventions to prevent harm as a result of consum-
ng alcohol. Areas such as transport economics and sexual health21 (2017) 1249–1262
would likely include economic evaluations relevant to this broader
scope of alcohol-induced harm and would provide a worthwhile
area for exploration in future research.
Whilst the English public health context provided a focal point
for the analysis of this review, the methodological findings are
relevant to public health economics researchers internationally.
Regardless of the setting, the inherent nature of public health inter-
ventions requires additional consideration for their evaluation,
therefore the methodological challenges discussed here should be
globally applicable.
6. Conclusions
This review echoes the findings of earlier research on the paucity
of economic evaluations of public health interventions. The lack
of evidence has implications for decision-making in public health,
specifically due to particular methodological issues such as the
types of interventions evaluated, the lack of consideration of long-
term outcomes, the lack of wider societal perspectives, and lack of
consideration of the impact on health inequity.
This review has also identified a gap in methods of evaluation
in the published literature with very limited reporting of the use
of CBA, CBA and priority-setting methods such as MCDA, PBMA,
option appraisal or SROI. Given that the literature has suggested
such methods of evaluation may  be useful to public health decision-
makers, these findings provide scope for future research into how
these may  be improved or adapted to aid uptake in the evaluation
of public health interventions.
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